Emotional Reactivity and Regulation Following Citalopram Therapy in Children and Adolescents with Anxiety Disorders

2017 ◽  
Vol 27 (1) ◽  
pp. 43-51 ◽  
Author(s):  
Tal Carthy ◽  
Noa Benaroya-Milshtein ◽  
Avi Valevski ◽  
Alan Apter
Keyword(s):  
Anxiety Disorders ◽  
Children And Adolescents ◽  
Emotional Reactivity

The Pharmacotherapy of Anxiety Disorders in Children and Adolescents

1992 ◽  
Vol 15 (1) ◽  
pp. 41-67 ◽  
Author(s):  
Stanley P. Kutcher ◽  
Sharon Reiter ◽  
David M. Gardner ◽  
Rachel G. Klein
Keyword(s):  
Anxiety Disorders ◽  
Children And Adolescents

Mood and Anxiety Disorders in Children and Adolescents

2001 ◽  
Author(s):  
David J. Nutt ◽  
Caroline Bell ◽  
Christine Masterson ◽  
Clare Short
Keyword(s):  
Anxiety Disorders ◽  
Children And Adolescents ◽  
Mood And Anxiety Disorders

scholarly journals Temporal trends in annual incidence rates for psychiatric disorders and self-harm among children and adolescents in the UK, 2003–2018

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Lukasz Cybulski ◽  
Darren M. Ashcroft ◽  
Matthew J. Carr ◽  
Shruti Garg ◽  
Carolyn A. Chew-Graham ◽  
...  
Keyword(s):  
Eating Disorders ◽  
Young People ◽  
Anxiety Disorders ◽  
Children And Adolescents ◽  
Autism Spectrum ◽  
Incidence Rates ◽  
Annual Incidence ◽  
Health Crisis ◽  
Self Harm ◽  
The Uk

Abstract Background There has been growing concern in the UK over recent years that a perceived mental health crisis is affecting children and adolescents, although published epidemiological evidence is limited. Methods Two population-based UK primary care cohorts were delineated in the Aurum and GOLD datasets of the Clinical Practice Research Datalink (CPRD). We included data from 9,133,246 individuals aged 1–20 who contributed 117,682,651 person-years of observation time. Sex- and age-stratified annual incidence rates were estimated for attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) (age groups: 1–5, 6–9, 10–12, 13–16, 17–19), depression, anxiety disorders (6–9, 10–12, 13–16, 17–19), eating disorders and self-harm (10–12, 13–16, 17–19) during 2003–2018. We fitted negative binomial regressions to estimate incidence rate ratios (IRRs) to examine change in incidence between the first (2003) and final year (2018) year of observation and to examine sex-specific incidence. Results The results indicated that the overall incidence has increased substantially in both boys and girls in between 2003 and 2018 for anxiety disorders (IRR 3.51 95% CI 3.18–3.89), depression (2.37; 2.03–2.77), ASD (2.36; 1.72–3.26), ADHD (2.3; 1.73–3.25), and self-harm (2.25; 1.82–2.79). The incidence for eating disorders also increased (IRR 1.3 95% CI 1.06–1.61), but less sharply. The incidence of anxiety disorders, depression, self-harm and eating disorders was in absolute terms higher in girls, whereas the opposite was true for the incidence of ADHD and ASD, which were higher among boys. The largest relative increases in incidence were observed for neurodevelopmental disorders, particularly among girls diagnosed with ADHD or ASD. However, in absolute terms, the incidence was much higher for depression and anxiety disorders. Conclusion The number of young people seeking help for psychological distress appears to have increased in recent years. Changes to diagnostic criteria, reduced stigma, and increased awareness may partly explain our results, but we cannot rule out true increases in incidence occurring in the population. Whatever the explanation, the marked rise in demand for healthcare services means that it may be more challenging for affected young people to promptly access the care and support that they need.

Cochrane Review: Pharmacotherapy for anxiety disorders in children and adolescents

2010 ◽  
Vol 5 (2) ◽  
pp. 555-628 ◽  
Author(s):  
Jonathan C Ipser ◽  
Dan J Stein ◽  
Susan Hawkridge ◽  
Lara Hoppe
Keyword(s):  
Anxiety Disorders ◽  
Children And Adolescents ◽  
Cochrane Review
Sign in / Sign up

Export Citation Format

Share Document